Correlation Between Level of Interleukin-37 and Rheumatoid Arthritis Progression

References

• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038. doi:10.1016/S0140-6736(16)30173-8
   PubMed Web of Science ®Google Scholar
• Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008;118(11):3537–3545. doi:10.1172/JCI36389
   PubMed Web of Science ®Google Scholar
• Nam JL, Takase-Minegishi K, Ramiro S, et al. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis. 2017;76(6):1113–1136. doi:10.1136/annrheumdis-2016-210713
   PubMed Web of Science ®Google Scholar
• Matsui T, Kuga Y, Kaneko A, et al. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis. 2007;66(9):1221–1226. doi:10.1136/ard.2006.063834
   PubMed Web of Science ®Google Scholar
• Bulau AM, Nold MF, Li S, et al. Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses. Proc Natl Acad Sci U S A. 2014;111(7):2650–2655. doi:10.1073/pnas.1324140111
   PubMed Web of Science ®Google Scholar
• Jia HL, Liu J, Han B. Reviews of interleukin-37: functions, receptors, and roles in diseases. Biomed Res Int. 2018;2018. doi:10.1155/2018/4793971
   Web of Science ®Google Scholar
• Ballak DB, van Diepen JA, Moschen AR, et al. IL-37 protects against obesity-induced inflammation and insulin resistance. Nat Commun. 2014;5:4711. doi:10.1038/ncomms5711
   PubMed Web of Science ®Google Scholar
• McNamee EN, Masterson JC, Jedlicka P, et al. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci U S A. 2011;108(40):16711–16716. doi:10.1073/pnas.1111982108
   PubMed Web of Science ®Google Scholar
• Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P, Dinarello CA. IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol. 2010;11(11):1014–U64. doi:10.1038/ni.1944
   PubMed Web of Science ®Google Scholar
• Sakai N, Van Sweringen HL, Belizaire RM, et al. Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells. J Gastroenterol Hepatol. 2012;27(10):1609–1616. doi:10.1111/j.1440-1746.2012.07187.x
   PubMed Web of Science ®Google Scholar
• Teng X, Hu Z, Wei X, et al. IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production. J Immunol. 2014;192(4):1815–1823. doi:10.4049/jimmunol.1300047
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang J, Tao J, Lu T. Elevated serum levels of interleukin-37 are associated with inflammatory cytokines and disease activity in rheumatoid arthritis. APMIS. 2015;123(12):1025–1031. doi:10.1111/apm.12467
   PubMed Web of Science ®Google Scholar
• Zhao PW, Jiang WG, Wang L, Jiang ZY, Shan YX, Jiang YF. Plasma levels of IL-37 and correlation with TNF-alpha, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis. PLoS One. 2014;9(5).
   Web of Science ®Google Scholar
• Dayer JM, Krane SM, Russell RG, Robinson DR. Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci U S A. 1976;73(3):945–949. doi:10.1073/pnas.73.3.945
   PubMed Web of Science ®Google Scholar
• Yuan ZC, Wang JM, Huang AF, Su LC, Li SJ, Xu WD. Elevated expression of interleukin-37 in patients with rheumatoid arthritis. Int J Rheum Dis. 2019;22(6):1123–1129. doi:10.1111/1756-185X.13539
   PubMed Web of Science ®Google Scholar
• Ding L, Hong X, Sun B, et al. IL-37 is associated with osteoarthritis disease activity and suppresses proinflammatory cytokines production in synovial cells. Sci Rep. 2017;7(1):11601. doi:10.1038/s41598-017-11397-5
   PubMed Web of Science ®Google Scholar
• Baecklund E, Iliadou A, Askling J, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006;54(3):692–701. doi:10.1002/art.21675
   PubMed Web of Science ®Google Scholar
• Wolfe F. The natural history of rheumatoid arthritis. J Rheumatol Suppl. 1996;44:13–22.
   PubMedGoogle Scholar
• Ye L, Jiang B, Deng J, et al. IL-37 alleviates rheumatoid arthritis by suppressing IL-17 and IL-17-triggering cytokine production and limiting Th17 cell proliferation. J Immunol. 2015;194(11):5110–5119. doi:10.4049/jimmunol.1401810
   PubMed Web of Science ®Google Scholar
• Ragaba D, Mobasher S, Shabaan E. Elevated levels of IL-37 correlate with T cell activation status in rheumatoid arthritis patients. Cytokine. 2019;113:305–310. doi:10.1016/j.cyto.2018.07.027
   PubMed Web of Science ®Google Scholar
• Xia T, Zheng XF, Qian BH, et al. Plasma interleukin-37 is elevated in patients with rheumatoid arthritis: its correlation with disease activity and Th1/Th2/Th17-related cytokines. Dis Markers. 2015;2015:1–6. doi:10.1155/2015/795043
   Web of Science ®Google Scholar
• Li C, Ji H, Cai Y, et al. Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment. J Interferon Cytokine Res. 2013;33(10):612–618. doi:10.1089/jir.2013.0001
   PubMed Web of Science ®Google Scholar
• Weidlich S, Bulau AM, Schwerd T, et al. Intestinal expression of the anti-inflammatory interleukin-1 Homologue IL-37 in pediatric inflammatory bowel disease. J Pediatr Gastr Nutr. 2014;59(2):E18–E26. doi:10.1097/MPG.0000000000000387
   PubMed Web of Science ®Google Scholar
• Song LJ, Qiu F, Fan YC, et al. Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus. J Clin Immunol. 2013;33(1):111–117. doi:10.1007/s10875-012-9791-z
   PubMed Web of Science ®Google Scholar
• Wan ZY, Sun Z, Song F, et al. Downregulated interleukin 37 expression associated with aggravation of intervertebral disc degeneration. Int J Clin Exp Pathol. 2014;7(2):656–662.
   PubMed Web of Science ®Google Scholar
• Boraschi D, Lucchesi D, Hainzl S, et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw. 2011;22(3):127–147. doi:10.1684/ecn.2011.0288
   PubMed Web of Science ®Google Scholar
• Isomaki P, Punnonen J. Pro- and anti-inflammatory cytokines in rheumatoid arthritis. Ann Med. 1997;29(6):499–507. doi:10.3109/07853899709007474
   PubMed Web of Science ®Google Scholar
• Pan Y, Wen X, Hao D, et al. The role of IL-37 in skin and connective tissue diseases. Biomed Pharmacother. 2020;122:109705. doi:10.1016/j.biopha.2019.109705
   PubMed Web of Science ®Google Scholar